Explore more publications!
Industry Reporter: Massachusetts
Got News to Share?

Industry Reporter: Massachusetts: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Industry Reporter: Massachusetts.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on December 6, 2025

TScan Therapeutics Announces Positive Updated Data from the ALLOHA™ Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition
December 6, 2025

TScan Therapeutics Announces Positive Updated Data from the ALLOHA™ Phase 1 Heme Trial at the 67th American Society of Hematology Annual Meeting and Exposition

Indeterminate GlobeNewswire
Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting
December 6, 2025

Fulcrum Therapeutics Announces Positive Initial Results from the 20 mg Dose Cohort of the Phase 1b PIONEER Trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

Indeterminate GlobeNewswire
Sapu Nano 宣佈由 Deciparticle™ 驅動的生物標記框架，可識別出最有可能對靜脈注射依維莫司納米藥物 Sapu003 產生反應的腫瘤
December 6, 2025

Sapu Nano 宣佈由 Deciparticle™ 驅動的生物標記框架，可識別出最有可能對靜脈注射依維莫司納米藥物 Sapu003 產生反應的腫瘤

Indeterminate GlobeNewswire
Remedy's Nutrition® Launches Cyst-Be-Gone™ — Advanced Herbal Formula to Support Natural Cyst & Tissue Wellness
December 6, 2025

Remedy's Nutrition® Launches Cyst-Be-Gone™ — Advanced Herbal Formula to Support Natural Cyst & Tissue Wellness

Indeterminate GlobeNewswire
BexBack Launches $100 Welcome Bonus and 100% Deposit Match as It Expands 100x Crypto Futures Trading Program
December 6, 2025

BexBack Launches $100 Welcome Bonus and 100% Deposit Match as It Expands 100x Crypto Futures Trading Program

Indeterminate GlobeNewswire
Mutuum Finance Completes Lending and Borrowing Smart Contracts Ahead of Security Review
December 6, 2025

Mutuum Finance Completes Lending and Borrowing Smart Contracts Ahead of Security Review

Indeterminate GlobeNewswire
Anthony Constantino’s ‘Thank You President Trump’ Album Release To Light Up Fontainebleau LIV Tonight; Hit song “Fight” has over 4 million views in 5 days
December 6, 2025

Anthony Constantino’s ‘Thank You President Trump’ Album Release To Light Up Fontainebleau LIV Tonight; Hit song “Fight” has over 4 million views in 5 days

Indeterminate GlobeNewswire
Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at the 67th American Society of Hematology (ASH)…
December 6, 2025

Nurix Therapeutics Presents New Data Demonstrating Durable, Deepening Responses in Phase 1 Trial of Bexobrutideg (NX-5948) in Patients with Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) at the 67th American Society of Hematology (ASH)…

Indeterminate GlobeNewswire
Cogent Biosciences Presents Full SUMMIT Results of Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 67th Annual Meeting of the American Society of Hematology (ASH)
December 6, 2025

Cogent Biosciences Presents Full SUMMIT Results of Bezuclastinib in Patients with NonAdvanced Systemic Mastocytosis (NonAdvSM) at the 67th Annual Meeting of the American Society of Hematology (ASH)

Indeterminate GlobeNewswire
Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition
December 6, 2025

Arvinas Presents Preclinical Data Supporting Mechanistic Synergies and Enhanced Antitumor Activity with the Combination of ARV-393 and Glofitamab at the 2025 American Society of Hematology Annual Meeting and Exposition

Indeterminate GlobeNewswire
Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Society of Hematology (ASH) Annual Meeting
December 6, 2025

Beam Therapeutics Reports Updated Data from BEACON Phase 1/2 Trial of ristoglogene autogetemcel (risto-cel) Highlighting Durable, Differentiated Profile in Sickle Cell Disease (SCD) at American Society of Hematology (ASH) Annual Meeting

Indeterminate GlobeNewswire
Bicara Therapeutics’ Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab Advances Pivotal Study Dose Selection on Track for First Quarter 2026
December 6, 2025

Bicara Therapeutics’ Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab Advances Pivotal Study Dose Selection on Track for First Quarter 2026

Indeterminate GlobeNewswire
Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations
December 6, 2025

Aptose’s Tuspetinib Triple Drug Therapy Featured at the 2025 ASH Annual Meeting; High Rate of Frontline Clinical Responses Continues Across AML Populations

Indeterminate GlobeNewswire
Canada’s Tenth Costco Business Centre is now open in East Gwillimbury
December 6, 2025

Canada’s Tenth Costco Business Centre is now open in East Gwillimbury

Indeterminate GlobeNewswire
Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting
December 6, 2025

Disc Medicine Presents Positive Initial Data from RALLY-MF Phase 2 Trial in Patients with Myelofibrosis (MF) and Anemia at the 67th American Society of Hematology (ASH) Annual Meeting

Indeterminate GlobeNewswire
Sapu Nano 公布新的药代动力学数据显示，与口服给药相比，静脉注射 Sapu003 可将依维莫司的胃肠道积累量减少 67 倍
December 6, 2025

Sapu Nano 公布新的药代动力学数据显示，与口服给药相比，静脉注射 Sapu003 可将依维莫司的胃肠道积累量减少 67 倍

Indeterminate GlobeNewswire
Sapu Nano 發表最新藥物動力學數據，顯示與口服劑量相比，靜脈注射 Sapu003 可將積聚在腸胃的依維莫司 (Everolimus) 量降低達 67 倍
December 6, 2025

Sapu Nano 發表最新藥物動力學數據，顯示與口服劑量相比，靜脈注射 Sapu003 可將積聚在腸胃的依維莫司 (Everolimus) 量降低達 67 倍

Indeterminate GlobeNewswire
Monument gibt erste Ergebnisse aus 16 Bohrlöchern des Erweiterungsbohrprogramms der Selinsing-Mine bekannt
December 6, 2025

Monument gibt erste Ergebnisse aus 16 Bohrlöchern des Erweiterungsbohrprogramms der Selinsing-Mine bekannt

Indeterminate GlobeNewswire
Cerevance Showcases Positive Phase 2 Results Demonstrating Significant Reduction in OFF Time with Solengepras as an Adjunctive Treatment in Parkinson’s Disease
December 6, 2025

Cerevance Showcases Positive Phase 2 Results Demonstrating Significant Reduction in OFF Time with Solengepras as an Adjunctive Treatment in Parkinson’s Disease

Indeterminate GlobeNewswire
Anika Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors ANIK
December 6, 2025

Anika Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors ANIK

Indeterminate GlobeNewswire
Show More

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions